The bacteriology of diabetic foot ulcers, with a special reference to multidrug resistant strains

Journal of Clinical and Diagnostic Research

Volumn 7, Issue 3, 2013, Pages 441-445

  Shanmugam, Priyadarshini ^a   Jeya, M ^a   Linda, Susan S ^a  

^a CHETTINAD HOSPITAL AND RESEARCH INSTITUTE   (India)

Author keywords

Antibiotic sensitivity; Bacterial profile; Diabetic foot ulcer

Indexed keywords

AMIKACIN; AMPICILLIN; AZITHROMYCIN; AZTREONAM; CARBAPENEMASE; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COLISTIN; ERYTHROMYCIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; LINEZOLID; MEROPENEM; OFLOXACIN; OXACILLIN; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; SULPERAZON; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CLINICAL ARTICLE; DIABETIC FOOT; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; PSEUDOMONAS; STAPHYLOCOCCUS AUREUS;

EID: 84874818999     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2013/5091.2794     Document Type: Article

References (18)

1. Pappu AK, Sinha A, Johnson A. Microbiological profile of diabetic foot ulcer. Calicut Med Journal. 2011; 9(3):e:1-4.
2. Shakil S, Khan AU. Infected foot ulcers in male and female diabetic patients: A clinico-bioinformative study. Ann Clin Microbiol Antimicrob. 2010; 9:1-10.
3. Sivaraman U, Kumar S, Joseph NM, Easow JM, Kandhakumari G. Microbiological study of diabetic foot infections. Indian J Med Specialities. 2011; 2(1):12-17.
4. Citron DM, Goldstein EJC, Merriam VC, Lipsky BA. Bacteriology of moderate to severe diabetic foot infections and invitro activity of antimicrobial agents. J Clin Microbiol. 2007; 45 (9):2819-2828.
5. Zubair M, Malik A, Ahmad J. Clinico-bacteriology and risk factors for the diabetic foot infection with multidrug resistant microorganisms in North India. Biol Med. 2010; 2 (4): 22-34.
6. Dowd SE, Randall DW, Yan Sun, McKeehan T, Smith E. Polymicrobial nature of chronic diabetic foot ulcer bioflm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP). PLoS ONE. 2008; 3(10): e3326-e3332.
7. Ramakant P, Verma AK, Misra R, Prasad KN. Changing Microbiological profile of pathogenic bacteria in diabetic foot infections: time to rethink on which empirical therapy to chose? Diabetologica. 2011; 54 (1): 58-64.
8. Anandi C, Alaguraja D, Natarajan V. Bacteriology of diabetic foot lesions. Indian J Med Microbiol. 2004; 22 (3): 175-178.
9. Ozer B, Kalaci A, Semerci E, Duran N, Davul S and Yanat AN. Infections and aerobic bacterial pathogens in diabetic foot. Afr J Microbiol Res. 2010; 4(20): 2153-2160.
10. Alavi SM, Khosravi AD, Sarami A, Dashtebozorg A, Montazeri EA. Bacteriologic study of diabetic foot ulcer. Pak J Med Sciences. 2007; 23(5): 681-684.
11. Sivanmaliappan T and Sevanan M. Antimicrobial susceptibility patterns of Pseudomonas aeruginosa from Diabetes Patients with Foot Ulcers. Int J Microbiol. 2011; Article ID 605195.
12. Prabhakar P, Rao AB and Hira,. Bacteriological study of diabetic foot ulcers. Trop Geogr Med. 1981; 33(3):249-252.
13. Gadepalli R, Dhawan B, Sreenivas V, Kapil A, Ammini AC. A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care. 2006; 29 (8): 1727-1732.
14. Shanker EM, Mohan V, Premalatha G, Srinivasan RS, Usha AR. Bacterial etiology of diabetic foot infection in south India. Eur J Int Med. 2005;16:567-570.
15. Pathare NA, Sathe SR. Antibiotic combinations in poly microbic diabetic foot infections. Indian J Med sci. 2001; 55(12):655-662.
16. Girish MB, Kumar TN and Srinivas R. Pattern of antimicrobials used to treat infected diabetic foot in a tertiary care hospital in Kolar. Int J Pharm Biomed Res. 2010; 1(2): 48-52.
17. Benwan KA, Mulla AA, Rotimi VO. A study of the microbiology of diabetic foot infections in a teaching hospital in Kuwait. J Infect Public health. 2012; 5(1):1-8.
18. The Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility testing, twenty first informational supplement, M100-S21, Clinical and Laboratory Standards Institute, 2011.